skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Biochemistry remover Base de dados/Biblioteca: ScienceDirect remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL
Material Type:
Artigo 		Adicionar ao Meu Espaço

The phase 3 DUO trial: duvelisib vs ofatumumab in relapsed and refractory CLL/SLL

Flinn, Ian W. ; Hillmen, Peter ; Montillo, Marco ; Nagy, Zsolt ; Illés, Árpád ; Etienne, Gabriel ; Delgado, Julio ; Kuss, Bryone J. ; Tam, Constantine S. ; Gasztonyi, Zoltán ; Offner, Fritz ; Lunin, Scott ; Bosch, Francesco ; Davids, Matthew S. ; Lamanna, Nicole ; Jaeger, Ulrich ; Ghia, Paolo ; Cymbalista, Florence ; Portell, Craig A. ; Skarbnik, Alan P. ; Cashen, Amanda F. ; Weaver, David T. ; Kelly, Virginia M. ; Turnbull, Barry ; Stilgenbauer, Stephan

Blood, 2018-12, Vol.132 (23), p.2446-2455 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets
The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets
Material Type:
Artigo 		Adicionar ao Meu Espaço

The purines: Potent and versatile small molecule inhibitors and modulators of key biological targets

Legraverend, Michel ; Grierson, David S.

Bioorganic & medicinal chemistry, 2006-06, Vol.14 (12), p.3987-4006 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Material Type:
Artigo 		Adicionar ao Meu Espaço

Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

Lampson, Benjamin L. ; Kasar, Siddha N. ; Matos, Tiago R. ; Morgan, Elizabeth A. ; Rassenti, Laura ; Davids, Matthew S. ; Fisher, David C. ; Freedman, Arnold S. ; Jacobson, Caron A. ; Armand, Philippe ; Abramson, Jeremy S. ; Arnason, Jon E. ; Kipps, Thomas J. ; Fein, Joshua ; Fernandes, Stacey ; Hanna, John ; Ritz, Jerome ; Kim, Haesook T. ; Brown, Jennifer R.

Blood, 2016-07, Vol.128 (2), p.195-203 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Design, synthesis and biological evaluation of 6-pyridylmethylaminopurines as CDK inhibitors

Wilson, Stuart C. ; Atrash, Butrus ; Barlow, Clare ; Eccles, Susan ; Fischer, Peter M. ; Hayes, Angela ; Kelland, Lloyd ; Jackson, Wayne ; Jarman, Michael ; Mirza, Amin ; Moreno, Javier ; Nutley, Bernard P. ; Raynaud, Florence I. ; Sheldrake, Peter ; Walton, Mike ; Westwood, Robert ; Whittaker, Steven ; Workman, Paul ; McDonald, Edward

Bioorganic & medicinal chemistry, 2011-11, Vol.19 (22), p.6949-6965 [Periódico revisado por pares]

Amsterdam: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Tanovea® for the treatment of lymphoma in dogs
Tanovea® for the treatment of lymphoma in dogs
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tanovea® for the treatment of lymphoma in dogs

De Clercq, Erik

Biochemical pharmacology, 2018-08, Vol.154, p.265-269 [Periódico revisado por pares]

England: Elsevier Inc

Texto completo disponível

Citações Citado por
6
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Hoellenriegel, Julia ; Meadows, Sarah A. ; Sivina, Mariela ; Wierda, William G. ; Kantarjian, Hagop ; Keating, Michael J. ; Giese, Neill ; O'Brien, Susan ; Yu, Albert ; Miller, Langdon L. ; Lannutti, Brian J. ; Burger, Jan A.

Blood, 2011-09, Vol.118 (13), p.3603-3612 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
7
Clinical severity in Lesch–Nyhan disease: The role of residual enzyme and compensatory pathways
Clinical severity in Lesch–Nyhan disease: The role of residual enzyme and compensatory pathways
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clinical severity in Lesch–Nyhan disease: The role of residual enzyme and compensatory pathways

Fu, Rong ; Sutcliffe, Diane ; Zhao, Hong ; Huang, Xinyi ; Schretlen, David J. ; Benkovic, Steve ; Jinnah, H.A.

Molecular genetics and metabolism, 2015-01, Vol.114 (1), p.55-61 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase
The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase
Material Type:
Artigo 		Adicionar ao Meu Espaço

The KH domain facilitates the substrate specificity and unwinding processivity of DDX43 helicase

Yadav, Manisha ; Singh, Ravi Shankar ; Hogan, Daniel ; Vidhyasagar, Venkatasubramanian ; Yang, Shizhuo ; Chung, Ivy Yeuk Wah ; Kusalik, Anthony ; Dmitriev, Oleg Y. ; Cygler, Miroslaw ; Wu, Yuliang

The Journal of biological chemistry, 2021-01, Vol.296, p.100085-100085, Article 100085 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Discovery and optimization of novel purines as potent and selective CB2 agonists
Discovery and optimization of novel purines as potent and selective CB2 agonists
Material Type:
Artigo 		Adicionar ao Meu Espaço

Discovery and optimization of novel purines as potent and selective CB2 agonists

Hollinshead, Sean P. ; Astles, Peter C. ; Chambers, Mark G. ; Johnson, Michael P. ; Palmer, John ; Tidwell, Michael W.

Bioorganic & medicinal chemistry letters, 2012-08, Vol.22 (15), p.4962-4966 [Periódico revisado por pares]

Amsterdam: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Comprehensive quantitative analysis of purines and pyrimidines in the human malaria parasite using ion-pairing ultra-performance liquid chromatography–mass spectrometry
Comprehensive quantitative analysis of purines and pyrimidines in the human malaria parasite using ion-pairing ultra-performance liquid chromatography–mass spectrometry
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comprehensive quantitative analysis of purines and pyrimidines in the human malaria parasite using ion-pairing ultra-performance liquid chromatography–mass spectrometry

Laourdakis, Christian D. ; Merino, Emilio F. ; Neilson, Andrew P. ; Cassera, Maria B.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2014-09, Vol.967, p.127-133 [Periódico revisado por pares]

Netherlands: Elsevier B.V

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (444)
  2. Revistas revisadas por pares (428)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (446)
  2. Book Chapters  (3)
  3. Livros  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1966  (25)
  2. 1966Até1979  (45)
  3. 1980Até1992  (64)
  4. 1993Até2006  (159)
  5. Após 2006  (158)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.